Dornase Alfa

ATC R05CB13 · 5 markets · 9 records

Dornase Alfa 5 markets · 9 records Forms

GB 3 records · 1 strengths

2.5 mg/2.5 mLliquidPulmozyme 2.5mg nebuliser liquid 2.5ml ampoules also in AU

AU 3 records · 3 strengths

2.5 mg/2.5 mLliquidPulmozyme also in GB
1 mg/mLliquidPULMOZYME Dornase alfa 1mg/mL spray solution unknown

Records without a stated strength · 1 Pulmozyme

US 1 records · 1 strengths

1 mgliquidPulmozyme also in CA

CA 1 records · 1 strengths

1 mgliquidPulmozyme also in US

HK 1 records · 1 strengths

Records without a stated strength · 1 PULMOZYME INHALATION SOL 1MG/ML

Side-by-side table

Strength / form / release	US	GB	CA	AU	HK
2.5 mg/2.5 mL liquid	not recorded	Pulmozyme 2.5mg nebuliser liquid 2.5ml ampoules	not recorded	Pulmozyme	not recorded
1 mg liquid	Pulmozyme	not recorded	Pulmozyme	not recorded	not recorded
1 mg/mL liquid	not recorded	not recorded	not recorded	PULMOZYME Dornase alfa 1mg/mL spray solution	not recorded
not disclosed unknown	not recorded	not recorded	not recorded	Pulmozyme	PULMOZYME INHALATION SOL 1MG/ML

Scroll horizontally for more markets →

Each country column shows the locally registered trade names — not translations.

“not disclosed” means the source does not publish the strength — it does not mean the product has none.

Hong Kong records are name/ingredient-level only: no strength, dosage form or registration status; on the register does not prove current supply.

Australia ARTG data has no registration-status column, so status is shown as unknown; being on the register does not mean currently marketed.

Back to the list

The same ingredient can carry completely different brand names in different countries, and the same name can point to a different ingredient. Listed by country — not interchangeable.

Discontinued, withdrawn or unverified-status products are hidden by default; Hong Kong and Australia records are shown as exceptions.